Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/23 16:30 | 1/12/23 | PTE | Health | BioPrd | Biological Products, (No Diag | Nolet Chris | CA | D | M.d | 0 | 0.00 | 0 | 36 | 14 | D | ||||||||||||||||
8/17/22 17:22 | 8/17/22 | PTE | Health | BioPrd | Biological Products, (No Diag | Cohen Peter A | NY | D | S | -11 | 1.28 | 0 | -9 | -54 | 7 | D | |||||||||||||||
8/16/22 19:16 | 8/16/22 | PTE | Health | BioPrd | Biological Products, (No Diag | Cohen Peter A | NY | D | S | -20 | 1.33 | 0 | -15 | -2 | 758 | D | |||||||||||||||
10/21/21 16:30 | 10/19/21 | PTE | Health | BioPrd | Biological Products, (No Diag | Seaburg David B | UT | D | S | -17 | 0.5538 | 0 | -31 | -2 | 1,339 | D | |||||||||||||||
9/2/21 16:30 | 9/1/21 | PTE | Health | BioPrd | Biological Products, (No Diag | Seaburg David B | UT | D | M.d | 0 | 0.00 | 0 | 32 | 2 | 1,370 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |